Active specific immunotherapy in malignant melanoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
1982 • 640 citations
T Cell Control of Antibody Production
1974 • 582 citations
Immunological factors which influence response to immunotherapy in malignant melanoma.
1970 • 462 citations
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
1975 • 434 citations
BCG lmmunotherapy of Malignant Melanoma
1974 • 430 citations
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
1968 • 390 citations
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes
1977 • 337 citations
Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
1983 • 266 citations
Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.
1986 • 255 citations
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.
1982 • 242 citations
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.
1988 • 239 citations
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
1987 • 224 citations
Ganglioside GM2 as a human tumor antigen (OFA-I-1).
1983 • 174 citations
Gangliosides of Human Melanoma2
1987 • 161 citations
Modulation of Suppressor-Cell Activity by Cimetidine in Patients with Common Variable Hypogammaglobulinemia
1985 • 141 citations
Augmentation of the human immune response by cyclophosphamide.
1982 • 136 citations
Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
1984 • 124 citations
Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide.
1976 • 117 citations
Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.
1981 • 100 citations
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists.
1984 • 96 citations
Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin.
1988 • 81 citations
Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes
1983 • 68 citations
Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine)
1988 • 66 citations
Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.
1976 • 64 citations
Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells
1985 • 61 citations
Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice.
1979 • 56 citations
PRELIMINARY RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT IMMUNOTHERAPY IN PATIENTS WITH MALIGNANT MELANOMA WHO HAVE LYMPH NODE METASTASES
1978 • 45 citations
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells
1983 • 44 citations
Active immunotherapy against cancer: present status.
1986 • 39 citations
Mechanism of histamine-induced inhibition of lymphocyte response to mitogens in mice
1981 • 36 citations
Suppressor cell activity in melanoma patients. I. Relation to tumor growth and immunoglobulin levels in vivo
1981 • 33 citations
Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
1983 • 27 citations
Prostaglandins and the immune response to cancer (review).
1981 • 27 citations
Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates.
1984 • 26 citations
Antigen mediation of a late-acting suppressor T-cell activity.
1977 • 25 citations
Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells
1985 • 25 citations
Studies of a Melanoma Tumor-Associated Antigen Detected in the Spent Culture Medium of a Human Melanoma Cell Line by Allogeneic Antibody. III. Physicochemical Properties23
1984 • 22 citations
Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
1983 • 21 citations
Studies of a Melanoma Tumor-Associated Antigen Detected in the Spent Culture Medium of a Human Melanoma Cell Line by Allogeneic Antibody. I. Purification and Development of a Radioimmunoassay23
1984 • 19 citations
Studies of a Melanoma Tumor-Associated Antigen Detected in the Spent Culture Medium of a Human Melanoma Cell Line by Allogeneic Antibody. II. Immunobiologic Characterization23
1984 • 14 citations
Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients
1988 • 14 citations
Oncofoetal antigen I: a target for immune cytolysis of human cancer
1979 • 13 citations
Prognostic significance of urinary antigen analysis by enzyme-linked immunosorbent assay in melanoma patients.
1983 • 9 citations
Characteristics of histamine receptors present on suppressor T cells in “healthy individuals”
1985 • 9 citations
Suppressor T-cell function in man: Suppression of immunoglobulin production by the direct action of immunoregulatory T cells on the B cell in four separate, distinct systems
1982 • 8 citations
Specific chemoimmunotherapy in tumor-bearing mice with extracted antigen, cyclophosphamide, and intrasplenic administration of interleukin-2
1986 • 7 citations
Book ReviewHealth Care of the Female Adolescent
1985 • 1 citations
Cited By (0)
No citing papers found in database